Regeneron

YTD

ALL

Trade Regeneron 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About REGN

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara.

CEO

Leonard S. Schleifer

CEOLeonard S. Schleifer

Employees

15,106

Employees15,106

Headquarters

Tarrytown, New York

HeadquartersTarrytown, New York

Founded

1988

Founded1988

Employees

15,106

Employees15,106

REGN Key Statistics

Market cap

55.44B

Market cap55.44B

Price-Earnings ratio

13.07

Price-Earnings ratio13.07

Dividend yield

0.34%

Dividend yield0.34%

Average volume

1.23M

Average volume1.23M

High today

$519.17

High today$519.17

Low today

$503.25

Low today$503.25

Open price

$508.51

Open price$508.51

Volume

838.43K

Volume838.43K

52 Week high

$1,211.20

52 Week high$1,211.20

52 Week low

$476.49

52 Week low$476.49

REGN News

Simply Wall St 12h

Shareholders Approve Bylaw Amendments at Regeneron Pharmaceuticals (NasdaqGS:REGN) Annual Meeting

recently conducted its Annual General Meeting, resulting in approved changes to its company bylaws. The amendments, along with the promising results from the EV...

Analyst ratings

74%

of 27 ratings

Buy

74.1%

Hold

22.2%

Sell

3.7%

People also own

Based on the portfolios of people who own REGN. This list is generated using Robinhood data, and it’s not a recommendation.